Cargando…

Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes

Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koshy, Shyny, Wu, Danli, Hu, Xueyou, Tajhya, Rajeev B., Huq, Redwan, Khan, Fatima S., Pennington, Michael W., Wulff, Heike, Yotnda, Patricia, Beeton, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795664/ https://www.ncbi.nlm.nih.gov/pubmed/24146918 http://dx.doi.org/10.1371/journal.pone.0076740

Ejemplares similares

Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts
por: Tajhya, Rajeev B, et al.
Publicado: (2016)

Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
por: Pethő, Zoltán, et al.
Publicado: (2016)

Erratum to: Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
por: Pethő, Zoltán, et al.
Publicado: (2016)

Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers
por: Anangi, Raveendra, et al.
Publicado: (2012)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
por: Pennington, Michael W., et al.
Publicado: (2015)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma
por: D’Alessandro, Giuseppina, et al.
Publicado: (2019)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
por: Rashid, M. Harunur, et al.
Publicado: (2013)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

Involvement of KCa3.1 channel activity in immediate perioperative cognitive and neuroinflammatory outcomes
por: Saxena, Sarah, et al.
Publicado: (2023)

The Ca(2+)-Activated K(+) Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
por: Chen, Yi-Je, et al.
Publicado: (2013)

Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
por: Lambertsen, Kate Lykke, et al.
Publicado: (2012)

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry
por: Koshy, Shyny, et al.
Publicado: (2010)

KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
por: Tanner, Mark R., et al.
Publicado: (2019)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia
por: Nguyen, Hai M., et al.
Publicado: (2016)

KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages
por: Grimaldi, A, et al.
Publicado: (2016)

Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction
por: Vera, O. Daniel, et al.
Publicado: (2023)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
por: Huq, Redwan, et al.
Publicado: (2016)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium
por: Lee, Bob Shih-Liang, et al.
Publicado: (2017)

KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy
por: Gross, Christina
Publicado: (2020)

Antigenic sites on the H(N) domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin
por: Vijayalakshmi Ayyar, B., et al.
Publicado: (2015)

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
por: Huang, Chunling, et al.
Publicado: (2014)

KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma
por: Song, Penghong, et al.
Publicado: (2017)

Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis
por: Lozano-Gerona, Javier, et al.
Publicado: (2020)

Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment
por: Wu, Danli, et al.
Publicado: (2015)

Killing the killers
por: De Paepe, Marianne, et al.
Publicado: (2014)

Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
por: Bergmann, Ralf, et al.
Publicado: (2017)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
por: Sevelsted Møller, Linda, et al.
Publicado: (2016)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease
por: Huang, Chunling, et al.
Publicado: (2021)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
por: Kuras, Zerrin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vcu8jaq7k8nv983ac09vsqas66